Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.
D. Zecher,¹ A. Cumpelik,² B. Ruhland,¹ B. Banas,¹ H. Hopfer,³ M. Dickenmann,⁴ J. Schifferli.²
¹Nephrology, Regensburg University Hospital, Regensburg, Germany; ²Biomedicine, Basel University Hospital, Basel, Switzerland; ³Pathology, Basel University Hospital, Basel, Switzerland; ⁴Nephrology, Basel University Hospital, Basel, Switzerland.
Background: The release of surface-derived microvesicles (MV) is a common phenomenon of cellular activation and occurs specifically as a consequence of terminal complement complex assembly…
2016 American Transplant Congress
Early Onset Hyperuricemia Is a Prognostic Marker for Kidney Allograft Dysfunction.
M. Han,¹ S. Yang,² I. Jung,³ S.-K. Park,⁴ Y. Kim,⁵ D. Han,⁵ Y. Kim,¹ S. Kim,⁶ J. Lee.⁷
¹Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; ²Kidney Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; ³Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; ⁴Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁵Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁶Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; ⁷Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Aim: It is not certain whether hyperuricemia is a true risk factor of kidney allograft failure. We investigated the association of hyperuricemia and graft outcome.Methods:…
2016 American Transplant Congress
Impact of Pre-Existing Comorbidities on Long-Term Patient and Graft Survival in Kidney Transplant Recipients.
F. Halleck, D. Khadzhynov, L. Lehner, E. Schrezenmeier, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.
Nephrology, Charité University, Berlin, Germany.
BACKGROUND Outcomes of patients with end-stage renal disease are largely affected by their comorbidities. Detailed data evaluating the impact of pre-transplant comorbidities on the long-term…
2016 American Transplant Congress
Kidney Transplant Patient Preferences and Trade-Offs for Outcomes After Transplantation.
M. Howell,^1,2 G. Wong,^1,2,3 J. Rose,⁴ A. Tong,^1,2 J. Craig,^1,2 K. Howard.²
¹Centre for Kidney Research, The Childrens Hospital at Westmead, Westmead, NSW, Australia; ²School of Public Health, University of Sydney, Sydney, NSW, Australia; ³Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia; ⁴Institute of Choice, University of South Australia, North Sydney, NSW, Australia.
Aim: To evaluate preferences and trade-offs patients may accept to avoid adverse outcomes of long-term immunosuppression. Background: Patient preferences in clinical decisions are increasingly relevant,…
2016 American Transplant Congress
Rurality Status Does Not Affect Kidney Transplant (KTP) Rates Among Veterans Compared to Medicare, Medicaid, and Private Insurance (PrivIns) Beneficiaries.
R. Kalil,^1,2 C. Franciscus,² A. O'Shea.^1,2
¹Internal Medicine/Nephrology, University of Iowa, Iowa City; ²Comprehensive Access and Delivery Research Evaluation (CADRE), Iowa City VAMC, Iowa City.
Background: A larger proportion of Veterans live in rural areas compared to non-Veterans. It is unknown whether rural status affects KTP rates among Veterans.Methods: Study…
2016 American Transplant Congress
Role of Induction Therapy in Low Immune Risk Kidney Transplant Recipients.
B. Chopra, K. Sureshkumar.
Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA.
Induction therapy improves outcomes in kidney transplant recipients (KTRs) by reducing early acute rejection. In the current era of potent maintenance immunosuppression, the role of…
2016 American Transplant Congress
Impact of Donor AKI on Outcome Following High KDPI Deceased Donor Kidney Transplantation.
D. Haakinson,¹ I. Qaqish,² M. Smith,³ H. Khamash,² K. Reddy,¹ R. Heilman.²
¹Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ; ²Nephrology, Mayo Clinic Arizona, Phoenix, AZ; ³Pathology, Mayo Clinic Arizona, Phoenix, AZ.
Background: Transplanting deceased donor kidneys with AKI does not appear to have negative impact on graft survival, however the impact of AKI on high KDPI…
2016 American Transplant Congress
Predicting Early Cardiac Death After Kidney Transplantation.
K. Balabhadrapatruni, A. Liu, N. Sarabu, E. Sanchez, J. Augustine.
Medicine, University Hospitals Case Medical Center, Cleveland, OH.
Background: Early cardiac mortality is a devastating occurrence after transplantation. We sought to analyze risk factors and patient characteristics, including the estimated post transplant survival…
2016 American Transplant Congress
Postoperative Rebound of Anti-Blood Type Antibodies and Antibody-Mediated Rejection After ABO-Incompatible Living Related Kidney Transplantation – Is Prophylactic Treatment Necessary?
H. Ishida, T. Kondo, T. Shimizu, T. Nozaki, K. Tanabe.
Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
PURPOSE: The role of postoperative anti-ABO titers in acute rejection under our current immunosuppressive regimen remains unclear. Some institutions recommend postoperative therapeutic plasma exchange to…
2016 American Transplant Congress
Association of Genetic Polymorphisms in Complement Independent Pathways with Donor Specific Antibodies in Kidney Allograft Recipients.
Y. Chang,^1,2 T. Shah,^1,3 D. Min.¹
¹Western University of Health Sciences, Pomona, CA; ²Mendez National Institute of Transplantation Foundation, Los Angeles, CA; ³St. Vincent Medical Center, Los Angeles, CA.
Background: It is known that detection of donor specific antibodies (DSA) is associated with antibody mediated rejection (AMR) and poor allograft outcomes. DSA mediates graft…